Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20196-69-4

Post Buying Request

20196-69-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20196-69-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 20196-69-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,1,9 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20196-69:
(7*2)+(6*0)+(5*1)+(4*9)+(3*6)+(2*6)+(1*9)=94
94 % 10 = 4
So 20196-69-4 is a valid CAS Registry Number.

20196-69-4Downstream Products

20196-69-4Relevant articles and documents

1,3:4,6-Di-O-benzylidene-D-mannitol as a source for novel chiral intermediates through regioselective reductive cleavage

Aravind, Appu,Baskaran, Sundarababu

, p. 743 - 745 (2005)

Synthetically useful chiral intermediates have been synthesized starting from 1,3:4,6-di-O-benzylidene-D-mannitol by regioselective reductive cleavage using BF3?Et2O and Et3SiH in high yields.

A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides

Miller, Gavin J.,Broberg, Karl. R.,Rudd, Claire,Helliwell, Madeleine R.,Jayson, Gordon C.,Gardiner, John M.

, p. 11208 - 11219 (2015/11/27)

d-Glucosamine derivatives bearing latent O4 functionality provide modified H/HS-type disaccharide donors for a final stage capping approach enabling introduction of conjugation-suitable, non-reducing terminal functionality to biologically important glycosaminoglycan oligosaccharides. Application to the synthesis of the first O4-terminus modified synthetic LMWH decasaccharide and an HS-like dodecasaccharide is reported.

Cysteine protease inhibitors

-

, (2008/06/13)

of the formula (IV): where: R1=R′C(O), R′SO2, R′=a bicyclic, saturated or unsaturated, 8-12 membered ring system containing 0-4 hetero atoms selected from S, O and N, which is optionally substituted with up to four substituents independently selected from groups a), b) and c) below; or R′=a monocyclic, saturated or unsaturated, 5-7 membered ring containing 0-3 hetero atoms selected from S, O and N, which monocyclic ring bears at least one substituent selected from group a) and/or c) and which may optionally bear one or two further substituents selected from group b); R4=H, C1-7-alkyl, Ar-C1-7-alkyl, Ar, C3-7-cycloalkyl; C2-7alkenyl; R3=C1-7-alkyl, C2-C7 alkenyl, C2-C7 alkenyl, C3-7-cycloalkyl, Ar-C1-7-alkyl, Ar; R5=C1-7-alkyl, halogen, Ar-C1-7-alkyl, C1-3-alkyl-CONR3R4 or a bulky amine R6 is H, C1-7-alkyl, Ar-C1-7-alkyl, C1-3-alkyl-SO2-Rix, C1-3-alkyl-C(O)—NHRix or CH2XAr q is 0 or 1 have utility as inhibitors of cysteine proteases such as cathepsin K and falcipain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20196-69-4